248 related articles for article (PubMed ID: 37225849)
1. Loss of DJ-1 function contributes to Parkinson's disease pathogenesis in mice via RACK1-mediated PKC activation and MAO-B upregulation.
Liu LL; Han Y; Zhang ZJ; Wang YQ; Hu YW; Kaznacheyeva E; Ding JQ; Guo DK; Wang GH; Li B; Ren HG
Acta Pharmacol Sin; 2023 Oct; 44(10):1948-1961. PubMed ID: 37225849
[TBL] [Abstract][Full Text] [Related]
2. DJ-1 protects cell death from a mitochondrial oxidative stress due to GBA1 deficiency.
Nam Y; Na J; Ma SX; Park H; Park H; Lee E; Kim H; Jang SM; Ko HS; Kim S
Genes Genomics; 2024 May; 46(5):519-529. PubMed ID: 38460098
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of DJ-1/PARK7-Mediated Parkinson's Disease.
Skou LD; Johansen SK; Okarmus J; Meyer M
Cells; 2024 Feb; 13(4):. PubMed ID: 38391909
[TBL] [Abstract][Full Text] [Related]
4. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
5. RNAi-mediated knockdown of DJ-1 leads to mitochondrial dysfunction via Akt/GSK-3ß and JNK signaling pathways in dopaminergic neuron-like cells.
Zhang XL; Wang ZZ; Shao QH; Zhang Z; Li L; Guo ZY; Sun HM; Zhang Y; Chen NH
Brain Res Bull; 2019 Mar; 146():228-236. PubMed ID: 30634017
[TBL] [Abstract][Full Text] [Related]
6. DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65.
Lin Z; Chen C; Yang D; Ding J; Wang G; Ren H
Cell Death Dis; 2021 Jul; 12(8):715. PubMed ID: 34274951
[TBL] [Abstract][Full Text] [Related]
7. Transduced Tat-DJ-1 protein protects against oxidative stress-induced SH-SY5Y cell death and Parkinson disease in a mouse model.
Jeong HJ; Kim DW; Woo SJ; Kim HR; Kim SM; Jo HS; Park M; Kim DS; Kwon OS; Hwang IK; Han KH; Park J; Eum WS; Choi SY
Mol Cells; 2012 May; 33(5):471-8. PubMed ID: 22526393
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of transcription factor SP1 produces neuroprotective effects through decreasing MAO B activity in MPTP/MPP
Yao L; Dai X; Sun Y; Wang Y; Yang Q; Chen X; Liu Y; Zhang L; Xie W; Liu J
J Neurosci Res; 2018 Oct; 96(10):1663-1676. PubMed ID: 30004136
[TBL] [Abstract][Full Text] [Related]
9. Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out rat model of Parkinson's disease.
Giangrasso DM; Furlong TM; Keefe KA
Neurobiol Dis; 2020 Feb; 134():104673. PubMed ID: 31734455
[TBL] [Abstract][Full Text] [Related]
10. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
Zuo L; Motherwell MS
Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
[TBL] [Abstract][Full Text] [Related]
11. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
[TBL] [Abstract][Full Text] [Related]
12. Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease.
Dolgacheva LP; Berezhnov AV; Fedotova EI; Zinchenko VP; Abramov AY
J Bioenerg Biomembr; 2019 Jun; 51(3):175-188. PubMed ID: 31054074
[TBL] [Abstract][Full Text] [Related]
13. DJ-1 modulates the unfolded protein response and cell death via upregulation of ATF4 following ER stress.
Yang J; Kim KS; Iyirhiaro GO; Marcogliese PC; Callaghan SM; Qu D; Kim WJ; Slack RS; Park DS
Cell Death Dis; 2019 Feb; 10(2):135. PubMed ID: 30755590
[TBL] [Abstract][Full Text] [Related]
14. MAO-B elevation in mouse brain astrocytes results in Parkinson's pathology.
Mallajosyula JK; Kaur D; Chinta SJ; Rajagopalan S; Rane A; Nicholls DG; Di Monte DA; Macarthur H; Andersen JK
PLoS One; 2008 Feb; 3(2):e1616. PubMed ID: 18286173
[TBL] [Abstract][Full Text] [Related]
15. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Activities of DJ-1 and Its Binding Compounds Against Neurodegenerative Diseases.
Inden M; Yanagisawa D; Hijioka M; Ariga H; Kitamura Y
Adv Exp Med Biol; 2017; 1037():187-202. PubMed ID: 29147910
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of DJ-1 in Dopaminergic Neurons by a Physically-Modified Saline: Implications for Parkinson's Disease.
Jana M; Dasarathy S; Ghosh S; Pahan K
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902085
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells.
Nagatsu T; Sawada M
J Neural Transm Suppl; 2006; (71):53-65. PubMed ID: 17447416
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
20. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B.
Guo B; Hu S; Zheng C; Wang H; Luo F; Li H; Cui W; Yang X; Cui G; Mak S; Choi TC; Ma ED; Wang Y; Lee SMY; Zhang Z; Han Y
Neuropharmacology; 2017 Nov; 126():12-24. PubMed ID: 28807675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
